Opicapone vs Co-beneldopa (Benserazide/levodopa)
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 10.7× as often as Opicapone in March 2026 — 79,414 items versus 7,392 in England.
7,392items
Opicapone · March 2026
NHSBSA Prescription Cost Analysis
79,414items
Co-beneldopa (Benserazide/levodopa) · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Opicapone versus Co-beneldopa (Benserazide/levodopa): national items dispensed by month
▬ Opicapone · ╌ Co-beneldopa (Benserazide/levodopa)
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Opicapone | Co-beneldopa (Benserazide/levodopa) |
|---|---|---|
| Items, March 2026 | 7,392 | 79,414 |
| Items, last 12 months | 82,077 | 949,699 |
| Net ingredient cost, March 2026 | £432,050 | £886,111 |
See the full profile for Opicapone or Co-beneldopa (Benserazide/levodopa).